To use all functions of this page, please activate cookies in your browser.
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
BismacineBismacine™, also known as Chromacine,[1] is a substance manufactured by American Biologics Corporation that is purported to treat Lyme disease. It is not a licensed pharmaceutical, but was granted a trademark by the US Patent and Trademark Office in January 2005. Bismacine contains high levels of bismuth, and two deaths are recorded in Kansas, USA, following the use of intravenous bismacine to treat Lyme disease.[2] Additional recommended knowledgeReferences
|
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Bismacine". A list of authors is available in Wikipedia. |